Afya (NASDAQ:AFYA) Upgraded by Wall Street Zen to “Strong-Buy” Rating

Wall Street Zen upgraded shares of Afya (NASDAQ:AFYA) from a buy rating to a strong-buy rating in a research note published on Saturday.

A number of other brokerages also recently commented on AFYA. Weiss Ratings restated a “hold (c)” rating on shares of Afya in a research note on Wednesday, October 8th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $22.00 price target (down from $24.50) on shares of Afya in a research report on Wednesday. Finally, UBS Group reduced their price objective on Afya from $19.00 to $18.00 and set a “buy” rating for the company in a research note on Thursday. Two investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $17.88.

Afya Trading Up 1.6%

NASDAQ:AFYA opened at $15.04 on Friday. The company has a market cap of $1.41 billion, a PE ratio of 10.82, a P/E/G ratio of 0.50 and a beta of 0.53. Afya has a 52 week low of $13.47 and a 52 week high of $19.90. The business’s 50 day moving average is $14.74 and its two-hundred day moving average is $15.13. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.21.

Institutional Investors Weigh In On Afya

A number of large investors have recently added to or reduced their stakes in the stock. Goldman Sachs Group Inc. lifted its position in shares of Afya by 167.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock worth $809,000 after purchasing an additional 28,226 shares during the last quarter. Swedbank AB acquired a new stake in shares of Afya during the 3rd quarter valued at about $1,092,000. Dynamic Technology Lab Private Ltd acquired a new position in shares of Afya in the 2nd quarter worth approximately $391,000. Carrera Capital Advisors bought a new position in shares of Afya during the second quarter valued at $1,750,000. Finally, Campbell & CO Investment Adviser LLC increased its holdings in shares of Afya by 31.5% during the second quarter. Campbell & CO Investment Adviser LLC now owns 51,340 shares of the company’s stock worth $917,000 after buying an additional 12,286 shares in the last quarter. Institutional investors own 88.02% of the company’s stock.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.